Table 2.

Clinical Characteristics of patients with biopsy proven NAFLD.

Variables (n = 147)	Mild to moderate fibrosis (n = 91)	Advanced fibrosis (n = 56)	P value	Test
Age	42.06 ± 11.86	55.08 ± 8.74	<0.001	t test
Sex
Male (n = 84) Female (n = 63)	48 (57%) 43 (68%)	36 (43%) 20 (32%)	0.16	Chi-square test
BMI	25.55 ± 3.61	27.04 ± 4.27	0.03	t test
DM
Yes (n = 48) No (n = 99)	12 (25%) 79(79.8)	36 (75%) 20 (20.2%)	<0.001	Chi-square test
Height (cm)	161.4 ± 9.58	164.15 ± 8.31	0.06	t test
Platelet	264,253 ± 60,166	137,750 ± 78,886	<0.001	t test
AST	23 (12, 82)	50.5 (13, 182)	<0.001	Mann–Whitney U Test
ALT	25.2(10,88)	30.5 (13,145)	0.19	Mann–Whitney U Test
AST/ALT	0.92 ± 0.39	1.40 ± 0.54	<0.001	t test
Albumin	4.5 ± 0.46	3.29 ± 0.7	<0.001	t test
INR	1.07 ± 0.231	1.08 ± 0.236	0.62	t test
NFS	−3.13 (−5.7,0.66)	1.4 (−3.33, 4.44)	<0.001	Mann–Whitney U Test
FIB-4	0.67 (0.17, 5.21)	5.03 (0.56, 17.5)	<0.001	Mann–Whitney U Test

Abbreviations: ALT = alanine aminotransferase; AST = aspartate aminotransferase; BMI = body mass index; DM; FIB-4 = Fibrosis Score 4; INR = Indian rupee; NFS = non-alcoholic fatty liver disease (NAFLD) Fibrosis Score.